Preparing for Gene Therapy Starts with Understanding Immunity – WFH
World Federation of Hemophilia – WFH shared a post on LinkedIn about a recent article by Hubert Darius J Daniel et al., published in Human Gene Therapy, adding:
“Preparing for gene therapy starts with understanding immunity.
This study examines baseline AAV antibody levels among people with and without hemophilia in India, informing screening approaches and access planning.”
Title: Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India
Authors: Hubert Darius J Daniel, Jaffar Farzana, Rajesh Kannangai, Sanjay Kumar, Kavitha M Lakshmi, Charnitkaur B Jashal, Hemant Dhamne, Varun Lahoti, Deepak Kanjwani, Aby Abraham, Kirsten Coleman, Arun Srivastava, Alok Srivastava, Asha Mary Abraham
More posts about World Federation of Hemophilia on Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease